The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.
Eliseev M.S.
V.A. Nasonova Research Institute of Rheumatology, Moscow, Russia
Denisov I.S.
V.A. Nasonova Research Institute of Rheumatology, Moscow, Russia
Markelova E.I.
V.A. Nasonova Research Institute of Rheumatology, Moscow, Russia
Glukhova S.I.
V.A. Nasonova Research Institute of Rheumatology, Moscow, Russia
Nasonov E.L.
"Research Institute of rheumatology n. a. V. A. Nasonova"
Independent risk factors for severe cardiovascular events in male patients with gout: Results of a 7-year prospective study
Journal: Therapeutic Archive. 2017;89(5): 10‑19
Views: 3555
Downloaded: 707
To cite this article:
Eliseev MS, Denisov IS, Markelova EI, Glukhova SI, Nasonov EL. Independent risk factors for severe cardiovascular events in male patients with gout: Results of a 7-year prospective study. Therapeutic Archive.
2017;89(5):10‑19. (In Russ.)
https://doi.org/10.17116/terarkh201789510-19
Aim. To determine risk factors for severe cardiovascular (CV) events (CVEs) in male patients with crystal-verified gout. Subjects and methods. 251 male patients with crystal-verified gout were prospectively followed up in 2003 to 2013. The mean follow-up period was 6.9±2.0 years. New severe CVE cases and deaths were recorded. Logistic regression was used to analyze the impact of traditional and other risk factors and allopurinol use on the risk for severe CVEs. Results. 32 patients died during the follow-up period. Severe CVEs were recorded in 58 (23.1%) patients; CVE deaths were notified in 22 (8.8%) patients. The risk of all severe CVEs was high for hypertension, increased serum high-sensitivity C-reactive protein (hs-CRP) level (>5 mg/l), ≥ stage III chronic kidney disease (CKD) (glomerular filtration rate, <60 ml/min/1.73 m2), alcohol intake (>20 g/day), coronary heart disease (CHD), and a family history of premature CHD. The risk of fatal CVEs was highest for elevated serum hs-CRP level, ≥stage III CKD, a family history of premature CHD, hypercholesterolemia, upper quartile of serum uric acid levels (>552 µmol/l), and regular intake of allopurinol. Conclusion. In addition to the traditional risk factors of CV catastrophes, the presence of chronic inflammation and the impact of high serum uric acid levels may explain the high frequency of CV catastrophes.
Keywords:
Authors:
Eliseev M.S.
V.A. Nasonova Research Institute of Rheumatology, Moscow, Russia
Denisov I.S.
V.A. Nasonova Research Institute of Rheumatology, Moscow, Russia
Markelova E.I.
V.A. Nasonova Research Institute of Rheumatology, Moscow, Russia
Glukhova S.I.
V.A. Nasonova Research Institute of Rheumatology, Moscow, Russia
Nasonov E.L.
"Research Institute of rheumatology n. a. V. A. Nasonova"
List of references:
Close metadata
Email Confirmation
An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.
Email Confirmation
Log in to the site using your account in one of the services
We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.